These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8928988)
1. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Frisch M; Hjalgrim H; Olsen JH; Melbye M Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988 [TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working Group Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [TBL] [Abstract][Full Text] [Related]
3. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555 [TBL] [Abstract][Full Text] [Related]
4. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488 [TBL] [Abstract][Full Text] [Related]
5. Incidence of invasive cancers following basal cell skin cancer. Levi F; La Vecchia C; Te VC; Randimbison L; Erler G Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413 [TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236 [TBL] [Abstract][Full Text] [Related]
7. Incidence of invasive cancers following squamous cell skin cancer. Levi F; Randimbison L; La Vecchia C; Erler G; Te VC Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621 [TBL] [Abstract][Full Text] [Related]
8. The association between malignant melanoma and noncutaneous malignancies. Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785 [TBL] [Abstract][Full Text] [Related]
9. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Taskinen M; Ranki A; Pukkala E; Jeskanen L; Kaitila I; Mäkitie O Am J Med Genet A; 2008 Sep; 146A(18):2370-5. PubMed ID: 18698627 [TBL] [Abstract][Full Text] [Related]
10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
11. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461 [TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive cancers following cutaneous malignant melanoma. Levi F; La Vecchia C; Randimbison L; Te VC; Erler G Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593 [TBL] [Abstract][Full Text] [Related]
13. [Risk of cancer among patients with cutaneous basal cell carcinoma]. Frisch M; Hjalgrim H; Olsen JH; Melbye M Ugeskr Laeger; 1998 May; 160(19):2882-7. PubMed ID: 9599567 [TBL] [Abstract][Full Text] [Related]
14. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
15. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074 [TBL] [Abstract][Full Text] [Related]
16. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Crocetti E; Carli P Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786 [TBL] [Abstract][Full Text] [Related]
17. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study. Holland-Bill L; Christiansen CF; Farkas DK; Donskov F; Jørgensen JOL; Sørensen HT Acta Oncol; 2018 Apr; 57(4):522-527. PubMed ID: 28920509 [TBL] [Abstract][Full Text] [Related]
19. Basal cell skin cancer and the risk of second primary cancers: a cancer registry-based study in Lithuania. Krilaviciute A; Vincerzevskiene I; Smailyte G Ann Epidemiol; 2016 Jul; 26(7):511-514. PubMed ID: 27262816 [TBL] [Abstract][Full Text] [Related]
20. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Hisada M; Chen BE; Jaffe ES; Travis LB J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]